Biologics

ab-sciex-extends-the-applicability-of-selexion-technology-swath-acquisition-and-proteinpilot-software-for-systems-biology-research

Ab Sciex launches MS solutions for advanced research

  • US
  • |
  • News

Singapore: Ab Sciex, a global leader in analytical technologies, has unveiled three new solutions for biological researchers to improve identification and quantitation of proteins, peptides, metabolites and lipids. The company extended... Read more

ge-healthcare-launches-biacore-t200-software-v

GE launches new software for molecular screening


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for... Read more

amgen-and-astellas-pharma-enter-a-strategic-alliance-to-develop-and-commercialize-five-amgen-pipeline-medicines-in-japan

Amgen & Astellas form JV, will co-develop biologics...


  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Amgen and Japanese firm Astellas Pharma have entered into a strategic alliance to co-develop and co-commercialize... Read more

Scientists find cellular origin of cervical cancer

Scientists find cellular origin of cervical cancer

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS), together with... Read more

Biotech-310x175_copy

Scientists trace origin of skin-deep immune cells

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep immune cells that... Read more

Biotech-310x175_copy

CSL files biologics license plea with FDA

  • Australia
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license application for standard... Read more

absciextriplequad-6500-mass-spec

AB Sciex launches next-gen TripleTOF 5600 System

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Life science analytical technologies company, AB Sciex, has launched the second generation TripleTOF 5600 System. The new TripleTOF... Read more

Biotech-310x175_copy

China Biologic names David Gao as CEO

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed Chairman David (Xiaoying)... Read more

brian-mcnamee-ceo-md-csl

Dr Brian McNamee: The force behind CSL

  • Australia
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

A doctor by training, Dr Brian A McNamee was enjoying himself in various job roles starting out as product manager, a job that he took on... Read more

dan-devine-patrys-australia

Patrys offers human antibodies for cancer cure

  • Australia
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Traditionally, researchers have utilized rodents to generate antibodies that attack human cancer tissues. In most cases, researchers alter... Read more

BioSpectrum emerging company award winner TaiMed Biologics

TaiMed Biologics taps on humanized mAb for HIV therapy

  • Taiwan
  • |
  • News
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver innovative medicines... Read more

biologics-facility-biocon

Asia biologics manufacturers face the 'quality challenge'

  • India
  • |
  • News
  • |
  • By Amrita Tejasvi, Singapore
  • |
  • 0 Comment

Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy. Even though countries... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X